Trovagene Inc (TROV.OQ)

TROV.OQ on NASDAQ Stock Exchange Capital Market

3.44USD
11 Jul 2014
Price Change (% chg)

$0.09 (+2.69%)
Prev Close
$3.35
Open
$3.32
Day's High
$3.50
Day's Low
$3.32
Volume
5,091
Avg. Vol
14,513
52-wk High
$10.26
52-wk Low
$3.32

TROV.OQ

Chart for TROV.OQ

About

TrovaGene, Inc. (TrovaGene) is a development-stage molecular diagnostic company that focuses on the development and marketing of urine-based nucleic acid tests for patient/disease screening and monitoring. The Company's novel tests predominantly use transrenal DNA (Tr-DNA) and transrenal RNA (Tr-RNA). The Company's technology is... (more)

Overall

Beta: -0.84
Market Cap (Mil.): $65.03
Shares Outstanding (Mil.): 18.90
Dividend: --
Yield (%): --

Financials

  TROV.OQ Industry Sector
P/E (TTM): -- 30.78 35.77
EPS (TTM): -0.77 -- --
ROI: -88.33 8.16 18.27
ROE: -144.37 13.05 19.16
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks